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Chapter I0 -
Preterm birth carries an increased risk for an impaired neurodevelopmental
outcome. Preterm infants, especially those born before 30 to 32 weeks'
gestation, often have serious medical complications that might lead to brain
damage. The assessment of the quality of spontaneous motility proved to be a
valuable and sensitive method for investigating the integrity of the neonatal
brain. The quality of the general movements (GMs), easily recognized and
frequently present in preterm infants, proved particularly valuable for assessing
neonatal brain function. Normal GMs are characterized by a large variability in
speed, amplitude, force and intensity. The sequence of arm, leg, head and
trunk movements is complex, with rotations superimposed on flexion and
extension, making the normal general movement look fluent. Abnormal GMs
lack this complexity, variability and fluency. At about the end of the second
month post-term, during the so-called age of transformation, the GMs acquire a
fidgety character. Fidgety GMs are circular movements of small amplitude and
moderate speed and variable acceleration of neck, trunk and limbs in all
directions. In preterm infants, this change in the characteristics of spontaneous
movements can be observed at about the same time provided the infant's age is
corrected for preterm birth.
This thesis deals with spontaneous motility in preterm infants. Both
qualitative and quantitative aspects of spontaneous motility were studied, from
videotape recordings, with the emphasis on the quality of GMs. In chapter L,
after a brief historical overview, a literature review is given on the present
knowledge on spontaneous motility. Several questions and unresolved problems
are stated. The aims of the study are introduced. These were:
- to determine whether the qualitative assessment of GMs is a sufficiently
sensitive diagnostic tool to discriminate between brain lesions and systemic
disease:
- to determine the relationship between the developmental course of
spontaneous motility, brain ultrasound findings and the neurological outcome in
three distinct groups of preterm infants whose developmental course of
spontaneous motility has not yet been elucidated.
The study groups consisted of:




- preterm, small-for-gestational ge infants;
- preterrn infants at risk for chronic lung disease, requiring dexamethasone
therapy.
The recording and assessment methods are described in detail in chapter 2.
The inter-observer reliability of the assessment of spontaneous motility is
reported. Considering the quantitative aspects of spontaneous motility, a good
inter-observer reliability was found for the occurrence of different movement
patterns and the duration of GMs. Inter-observer agreement on the assessment
of the quality of GMs was even better: 95%, using kappa 0.89 (95%
confidence interval 0.86-0.93).
Chapter 3 describes observations on spontaneous motility in preterm
infants with septicaemia, providing some answers to the question whether the
assessment method is sufficiently sensitive to differentiate between brain
dysfunction and severe illnesses unaccompanied by brain dysfunction. Our
study demonstrated that severe infections such as septicaemia have a limited
influence on the quality of GMs in preterm infants. The GMs may have a
transient sluggish character. At first notice, this can be mistaken for 'poor
repertoire' GMs. However, the richness in complexity and variability,
particularly the sequencing of moving parts, including superimposed rotations,
is strikingly different from true 'poor repertoire' GMs. Therefore, the global
assessment of the quality of GMs is normal. This indicates that it is possible to
discriminate between abnormal GMs due to cerebral lesions and sluggish GMs
due to severe systemic infections, provided complexity of the GMs is
considered as the main characteristic when judging normality of GM quality.
Chapter 4 deals with the significance of localization and duration of
transient periventricular echodensities for the quality of GMs. This was studied
from birth until the 20th week post-term in a group of appropriate-for-
gestational age infants. The relationship between ultrasound findings and GM
quality and the neurological outcome was also established. Echodensities in the
frontal white matter, which resolved before the 14th day of life, did not seem
to have any impact on the individual developmental trajectories of GM quality.
Echodensities, especially in the parieto-occipital white matter, lasting for more
than 14 days, were found to be related to abnormal developmental trajectories
of the quality of GMs. Parieto-occipital echodensities with a duration of up to
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14 days resulted in abnormal GMs in some infants, but led to normal GMs in
others. This indicates the difficulty of establishing the severity of echodensities
on the ultrasound appearance alone. The assessment of GM quality helped to
identify those infants who were at risk for developmental problems and those
who were not. Normal GMs in infants with transient echodensities indicate that
there is no brain dysfunction; these infants had a good prognosis. The
persistent presence of abnormal GMs are predictive of an impaired neurological
outcome. The quality of fidgety GMs is of great value to establish the
prognosis for the outcome in infants with transiently abnormal GMs.
Chapters 5 and 6 document the development of spontaneous motility in a
group of preterm intrauterine growth-retarded infants from birth until
approximately 20 weeks post-term. Almost all showed evidence of placental
dysfunction. Data on the quantity of spontaneous movements are provided in
chapter 5. The incidence of various frequently occurring movement patterns
did not differ from normative data previously found in low-risk appropriate-for-
gestational age preterm infants (the reference group). This indicates that
intrauterine growth retardation does not influence the normal developmental
course with respect to the rate of occurrence of movement patterns. We
evaluated the quantitative aspects of spontaneous motility according to both
postmenstrual age and postnatal age, because possible changes in the quantity
of spontaneous motility due to the deterioration of the fetal condition just
before birth might thus become evident. However, only an increased duration
of GMs with increasing postnatal age was revealed, a tendency not found in the
reference group. A possible explanation is a reduced duration of GMs in the
first week after birth, after a period in which the fetal condition had been more
or less severely compromised.
The developmental course of the quality of GMs for this group of preterm,
small-for-gestational ge infants is reported in chapter 6. Most infants showed
abnormal GMs during their preterm period. The longitudinal approach of this
sfudy revealed that the quality of GMs normalized in the majority of the infants
after term age. Furthermore, a clear relationship was demonstrated between
specific developmental trajectories of GM quality and neurological outcome.
The quality of fidgety GMs, in particular, was predictive for the final outcome.
By contrast, the neurological outcomes were not correlated to brain ultrasound
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findings, obstetrical variables indicative of fetal distress, the degree of growth
retardation or the extent of brain sparing. A large proportion of infants with
normal brain ultrasound scans appeared to have abnormal GMs. This finding
suggests that the chronically reduced fetal supply of oxygen or nutrients or both
may lead to longer lasting but often transient brain dysfunction, which is not
necessarily caused by haemorrhagic or ischaemic lesions detectable on
ultrasound scans. The assessment of the quality of GMs in preterm, small-for-
gestational age infants is a sensitive method with a high predictive value for
eventual outcome, similar to previous studies of preterm, appropriate-for-
gestational age infants.
Chapter 7 describes the effects of dexamethasone treatment on spontaneous
movements in preterm infants at risk for chronic lung disease. This longitudinal
study demonstrated that dexamethasone had profound acute effects on the
quantity and quality of GMs, as early as 24 hours after the first dose of
dexamethasone had been given. The incidence and duration of GMs was
substantially reduced and after detailed analysis of the quality of GMs, we
found a reduction of speed and amplitude. In this group of high-risk preterm
infants, we also found a clear relationship between the severity of brain
ultrasound abnormalities and specific developmental trajectories of GM quality
and the neurological outcome, confirming previous reports. It was impossible
to discriminate between the effects of brain lesions and possible adverse long-
term effects of dexamethasone on spontaneous motor activity. Nevertheless, the
acute changes were such that cautious use of systemic dexamethasone therapy
in preterm infants is recommended by us, until more is known about long-term
neurological sequelae.
Chapter 8 reports a multi-centre study on the quality of fidgety GMs in a
large group of normal and abnormal, preterm and term infants, in relation to
the final neurological outcome and the quality of GMs prior to the age of
transformation. The quality of fidgety GMs in young infants yielded
information for making valid predictions about later neurological outcome long
before the first signs of spasticity appeared. Not only are abnormnl or absent
fidgety GMs indicative of a poor outcome but norm.al fidgety GMs are an
excellent marker for a normal neurological outcome. The assessment of the
quality of GMs before the onset of fidgety movements had an equally high
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sensitivity but its specificity was considerably lower. Many of the earlier GM
abnormalities were transient phenomena and normalized before or at the
appearance of fidgety movements. On the other hand, infants with abnormal or
absent fidgety movements did not normalize, bar a few exceptions (5 7o), but
retained abnormal neurological signs after the age when fidgety movements
normally disappear.
In chapter 9 the studies are placed within general perspectives. Implications
for future studies are discussed.
In conclusion, our studies have shown that assessment of the quality of
GMs is a powerful diagnostic tool for evaluating brain function in preterm
infants. It is non-intrusive, quick, and can be applied reliably in ill preterm
infants. After the age of transformation, the quality of fidgety movements is an
excellent marker for the eventual neurological outcome. The method is a
valuable extension of other ways of assessing the central nervous system in
young infants, in particular brain ultrasound imaging. The observation of
general movements, preferably from videotape recordings, should be included
in the standard neurological examination during the preterm and term period.
Moreover, it is a useful tool for investigating the influences of disease and
medication on the young central nervous system.
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